MBX Biosciences

About

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel,Indiana,United States
11 - 50
https://www.mbxbio.com

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $115M
Industries: Biotechnology,Health Care,Therapeutics,Wellness
Founded date: Jan 1, 2019
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: MBX Biosciences, Inc.

MBX Biosciences is a biotechnology company that develops therapies to treat rare endocrine diseases where there is inadequate treatment available. It focuses on the discovery, development, and commercialization of first-in-class endocrine therapeutics.

The company was founded in 2018 and headquartered in Carmel, Indiana.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$174.90M

MBX Biosciences has raised a total of $174.90M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2022 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 14, 2022	Series B	$115M	6	Wellington Management	—	Detail
Jul 27, 2020	Series A	$34.60M	6	Frazier Healthcare Partners	—	Detail
Apr 25, 2019	Debt Financing	$25.30M	—	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

10

MBX Biosciences is funded by 10 investors. Wellington Management and Frazier Healthcare Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Wellington Management	Yes	Series B
Frazier Healthcare Partners	Yes	Series A
Norwest Venture Partners	—	Series B
Frazier Life Sciences	—	Series B
New Enterprise Associates	—	Series B
OrbiMed	—	Series B
RA Capital Management	—	Series B
BioCrossroads	—	Series A
Indiana University Philanthropic Venture Fund	—	Series A
Twilight Venture Partners	—	Series A